Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2012

01-08-2012 | Original Investigation

Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes

Authors: Melina Villalba, Melissa Hott, Carolina Martin, Blanca Aguila, Sharin Valdivia, Claudia Quezada, Ángara Zambrano, Margarita I. Concha, Carola Otth

Published in: Medical Microbiology and Immunology | Issue 3/2012

Login to get access

Abstract

Herpes simplex virus type 1 (HSV-1) is the most common pathogenic cause of sporadic acute encephalitis and it produces latent persistent infection lifelong in infected individuals. Brain inflammation is associated with activation of glial cells, which can detect pathogen-associated molecular patterns (PAMPs) through a variety of pattern-recognition receptors (PRR), including Toll-like receptors (TLRs). In this study, we evaluated the expression and activation of TLR2, TLR3, and TLR4 in HSV-1-infected astrocyte and neuronal primary cultures. Our results showed a clear induction in TLR2 and TLR4 expression in astrocytes as early as 1 h after HSV-1 infection, whereas no significant change was observed in neurons. In addition, infected astrocytes showed increased levels of interferon regulatory factors IRF3 and IRF7, interferon β (INFβ), interleukin 6 (IL6), and serum amyloid A (SAA3) transcripts, as well as phospho-IRF3 protein. These effects seemed to be dependent on viral replication since previous treatment of the cells with acyclovir resulted in low levels of TLRs expression and activation even after 4 h post-infection. These results suggest that reactivation of HSV-1 at the central nervous system (CNS) would likely induce and activate TLR2 and TLR4 receptors directly through interaction of astrocytes with the pathogen and also indirectly by endogenous ligands produced locally, such as serum amyloid protein, potentiating the neuroinflammatory response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer’s disease patients. J Med Virol 75(2):300–306PubMedCrossRef Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer’s disease patients. J Med Virol 75(2):300–306PubMedCrossRef
2.
go back to reference Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS ONE 3(11):e3637. doi:10.1371/journal.pone.0003637 PubMedCrossRef Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS ONE 3(11):e3637. doi:10.​1371/​journal.​pone.​0003637 PubMedCrossRef
3.
go back to reference Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 349(9047):241–244PubMedCrossRef Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 349(9047):241–244PubMedCrossRef
4.
go back to reference Itzhaki RF, Wozniak MA (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer’s disease and other disorders. Prog Lipid Res 45(1):73–90PubMedCrossRef Itzhaki RF, Wozniak MA (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer’s disease and other disorders. Prog Lipid Res 45(1):73–90PubMedCrossRef
5.
go back to reference Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging 25(5):619–627PubMedCrossRef Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging 25(5):619–627PubMedCrossRef
6.
go back to reference Dobson CB, Wozniak MA, Itzhaki RF (2003) Do infectious agents play a role in dementia? Trends Microbiol 11(7):312–317PubMedCrossRef Dobson CB, Wozniak MA, Itzhaki RF (2003) Do infectious agents play a role in dementia? Trends Microbiol 11(7):312–317PubMedCrossRef
7.
go back to reference Zambrano A, Solis L, Salvadores N, Cortés M, Lerchundi R, Otth C (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimer Dis 14(3):1–11 Zambrano A, Solis L, Salvadores N, Cortés M, Lerchundi R, Otth C (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimer Dis 14(3):1–11
8.
go back to reference Otth C, Zambrano A, Concha M (2009) The possible link between herpes simplex virus type 1 infection and neurodegeneration. In: Maccioni RB, Perry G (eds) Current hypotheses and research Milestones in Alzheimer’s disease. Springer, New York, pp 181–188. ISBN 978-0-387-87994-9 Otth C, Zambrano A, Concha M (2009) The possible link between herpes simplex virus type 1 infection and neurodegeneration. In: Maccioni RB, Perry G (eds) Current hypotheses and research Milestones in Alzheimer’s disease. Springer, New York, pp 181–188. ISBN 978-0-387-87994-9
9.
go back to reference Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with Herpes Simplex Virus type 1. J Alzheimer Dis 23(3):513–520 Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with Herpes Simplex Virus type 1. J Alzheimer Dis 23(3):513–520
10.
go back to reference Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801PubMedCrossRef Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801PubMedCrossRef
11.
go back to reference Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem 20(6):947–956PubMedCrossRef Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem 20(6):947–956PubMedCrossRef
12.
go back to reference He RL, Zhou J, Hanson CZ, Chen J, Cheng N, Ye RD (2009) Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113(2):429–437PubMedCrossRef He RL, Zhou J, Hanson CZ, Chen J, Cheng N, Ye RD (2009) Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113(2):429–437PubMedCrossRef
13.
go back to reference Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A (2008) Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83(5):1174–1180PubMedCrossRef Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A (2008) Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83(5):1174–1180PubMedCrossRef
14.
go back to reference Cheng N, He R, Tian J, Ye PP, Ye RD (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181(1):22–26PubMed Cheng N, He R, Tian J, Ye PP, Ye RD (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181(1):22–26PubMed
15.
go back to reference Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD (1997) Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer’s disease brain. Neurosci Lett 225(2):73–76PubMedCrossRef Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD (1997) Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer’s disease brain. Neurosci Lett 225(2):73–76PubMedCrossRef
16.
go back to reference Kindy MS, Yu J, Guo JT, Zhu H (1999) Apolipoprotein serum amyloid A in Alzheimer’s disease. J Alzheimer Dis 1(3):155–167 Kindy MS, Yu J, Guo JT, Zhu H (1999) Apolipoprotein serum amyloid A in Alzheimer’s disease. J Alzheimer Dis 1(3):155–167
17.
go back to reference Chung TF, Sipe JD, McKee A, Fine RE, Schreiber BM, Liang JS, Johnson RJ (2000) Serum amyloid A in Alzheimer’s disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 7(2):105–110PubMedCrossRef Chung TF, Sipe JD, McKee A, Fine RE, Schreiber BM, Liang JS, Johnson RJ (2000) Serum amyloid A in Alzheimer’s disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 7(2):105–110PubMedCrossRef
19.
go back to reference Castro MA, Pozo M, Cortés C, García M, Concha II, Nualart F (2007) Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. J Neurochem 102(3):773–782PubMedCrossRef Castro MA, Pozo M, Cortés C, García M, Concha II, Nualart F (2007) Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. J Neurochem 102(3):773–782PubMedCrossRef
20.
go back to reference Otth C, Torres M, Ramirez A, Fernandez JC, Castro M, Rauch MC, Brito M, Yanez AJ, Rodriguez-Gil JE, Slebe JC, Concha II (2007) Novel identification of peripheral dopaminergic D2 receptor in male germ cells. J Cell Biochem 100(1):141–150PubMedCrossRef Otth C, Torres M, Ramirez A, Fernandez JC, Castro M, Rauch MC, Brito M, Yanez AJ, Rodriguez-Gil JE, Slebe JC, Concha II (2007) Novel identification of peripheral dopaminergic D2 receptor in male germ cells. J Cell Biochem 100(1):141–150PubMedCrossRef
21.
go back to reference Du F, Qian ZM, Zhu L, Wu XM, Qian C, Chan R, Ke Y (2010) Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures. J Cell Biochem 109(1):30–37PubMed Du F, Qian ZM, Zhu L, Wu XM, Qian C, Chan R, Ke Y (2010) Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures. J Cell Biochem 109(1):30–37PubMed
22.
go back to reference Hua F, Ma J, Ha T, Kelley JL, Kao RL, Schweitzer JB, Kalbfleisch JH, Williams DL, Li C (2009) Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res 1262:100–108PubMedCrossRef Hua F, Ma J, Ha T, Kelley JL, Kao RL, Schweitzer JB, Kalbfleisch JH, Williams DL, Li C (2009) Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res 1262:100–108PubMedCrossRef
23.
go back to reference Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H, Hara H (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171(1):258–267PubMedCrossRef Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H, Hara H (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171(1):258–267PubMedCrossRef
24.
go back to reference Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR (2005) Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175(7):4189–4193PubMed Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR (2005) Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175(7):4189–4193PubMed
25.
go back to reference Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA (2012) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86(4):2273–2281PubMedCrossRef Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA (2012) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86(4):2273–2281PubMedCrossRef
27.
go back to reference Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV (2009) Toll-like receptors in neurodegeneration. Brain Res Rev 59(2):278–292PubMedCrossRef Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV (2009) Toll-like receptors in neurodegeneration. Brain Res Rev 59(2):278–292PubMedCrossRef
28.
go back to reference Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P, Epstein AL (2009) Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol 90(Pt 9):2209–2220PubMedCrossRef Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P, Epstein AL (2009) Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol 90(Pt 9):2209–2220PubMedCrossRef
29.
go back to reference Collins SE, Noyce RS, Mossman KL (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78(4):1706–1717PubMedCrossRef Collins SE, Noyce RS, Mossman KL (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78(4):1706–1717PubMedCrossRef
30.
go back to reference Noyce RS, Collins SE, Mossman KL (2009) Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 83(9):4013–4422PubMedCrossRef Noyce RS, Collins SE, Mossman KL (2009) Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 83(9):4013–4422PubMedCrossRef
31.
go back to reference Paladino P, Cummings DT, Noyce RS, Mossman KL (2006) The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177(11):8008–8016PubMed Paladino P, Cummings DT, Noyce RS, Mossman KL (2006) The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177(11):8008–8016PubMed
32.
go back to reference Rasmussen SB, Sørensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, Paludan SR (2007) Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 81(24):13315–13324PubMedCrossRef Rasmussen SB, Sørensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, Paludan SR (2007) Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 81(24):13315–13324PubMedCrossRef
33.
go back to reference Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, Öörni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and cathepsin B-sensitive pathway. J Immunol 186(11):61119–66128CrossRef Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, Öörni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and cathepsin B-sensitive pathway. J Immunol 186(11):61119–66128CrossRef
34.
go back to reference Chiba T, Han CY, Vaisar T, Shimokado K, Kargi A, Chen MH, Wang S, McDonald TO, O’Brien KD, Heinecke JW, Chait A (2009) Serum amyloid A3 does not contribute to circulating SAA levels. J Lipid Res 50(7):1353–1362PubMedCrossRef Chiba T, Han CY, Vaisar T, Shimokado K, Kargi A, Chen MH, Wang S, McDonald TO, O’Brien KD, Heinecke JW, Chait A (2009) Serum amyloid A3 does not contribute to circulating SAA levels. J Lipid Res 50(7):1353–1362PubMedCrossRef
35.
go back to reference Reigstad CS, Bäckhed F (2010) Microbial regulation of SAA3 expression in mouse colon and adipose tissue. Gut Microbes 1(1):55–57PubMedCrossRef Reigstad CS, Bäckhed F (2010) Microbial regulation of SAA3 expression in mouse colon and adipose tissue. Gut Microbes 1(1):55–57PubMedCrossRef
36.
go back to reference Conde J, Gomez R, Bianco G, Scotese M, Lear P, Dieguez C, Gomez-Reino J, Lago F, Gualillo O (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70(3):551–559 Conde J, Gomez R, Bianco G, Scotese M, Lear P, Dieguez C, Gomez-Reino J, Lago F, Gualillo O (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70(3):551–559
37.
go back to reference Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, Fitzgerald KA, Flavell RA, Eisenbarth SC, Poynter ME (2011) Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 187(1):64–73PubMedCrossRef Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, Fitzgerald KA, Flavell RA, Eisenbarth SC, Poynter ME (2011) Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 187(1):64–73PubMedCrossRef
38.
go back to reference Ridder DA, Bulashevska S, Chaitanya GV, Babu PP, Brors B, Eils R, Schneider A, Schwaninger M (2009) Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis. Brain Res 1272:3–13PubMedCrossRef Ridder DA, Bulashevska S, Chaitanya GV, Babu PP, Brors B, Eils R, Schneider A, Schwaninger M (2009) Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis. Brain Res 1272:3–13PubMedCrossRef
39.
go back to reference Ejarque-Ortíz A, Medina MG, Tusell JM, Pérez-González AP, Serratosa J, Saura J (2007) Upregulation of CCAAT/enhancer binding protein β in activated astrocytes and microglia. Glia 55(2):178–188PubMedCrossRef Ejarque-Ortíz A, Medina MG, Tusell JM, Pérez-González AP, Serratosa J, Saura J (2007) Upregulation of CCAAT/enhancer binding protein β in activated astrocytes and microglia. Glia 55(2):178–188PubMedCrossRef
Metadata
Title
Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes
Authors
Melina Villalba
Melissa Hott
Carolina Martin
Blanca Aguila
Sharin Valdivia
Claudia Quezada
Ángara Zambrano
Margarita I. Concha
Carola Otth
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2012
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-012-0247-0

Other articles of this Issue 3/2012

Medical Microbiology and Immunology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.